Skip to main content

Table 4 Diagnostic and clinical features of 7 cases with the ‘Greek-Cypriot’ p.Leu346Pro (L346P) mutation in compound heterozygosity

From: Demographic characteristics, clinical and laboratory features, and the distribution of pathogenic variants in the CFTR gene in the Cypriot cystic fibrosis (CF) population demonstrate the utility of a national CF patient registry

Features

Case 1

Case 2

Case 3

Case 4

Case 5

Case 6

Case 7

Diagnosis

CF

CF

CF

CF

CF

CF

CFTR-RD

Gender

Male

Female

Male

Female

Male

Female

Female

Age (years)

19.7

21

24.3

27.8

32.2

48.5

72.9

Age at diagnosis (years)

0

0.5

1

0.4

5.7

25.2

47.7

Other CFTR mutation

p.Phe508del

p.Phe508del

p.Phe508del

p.Tyr515X

p.Phe508del

CFTRdele2,3

p.Met348Lys

Sweat chloride (mmol/L)a

75

106

80

103.5

66.5

86

19

Clinical presentation

PS

RS; EI

EI; FTT

EI; FTT; GS

EI; FTT; GS

RS; FTT

FH

Digital clubbing

No

ND

No

ND

Yes

ND

ND

BMI z-scoreb

− 0.2

0.1

1.2

ND

− 0.2

ND

ND

FEV1 z-scorec

− 0.9

− 2.4

− 0.2

ND

− 4.6

ND

ND

Pancreatic insufficiencyd

Yes

ND

No

ND

Yes

ND

ND

Chronic P. aeruginosa col.e

ND

ND

ND

ND

Yes

ND

ND

Bronchiectasisf

Moderate

ND

No

Moderate

Severe

ND

ND

  1. aMean value (mmol/L) of all performed sweat chloride tests
  2. bBMI z-score measured on date of best FEV1 z-score measurement in follow-up year
  3. cBest FEV1 z-score measured in follow-up year
  4. dPancreatic insufficiency defined as pancreatic enzyme supplementation requirement
  5. eChronic pulmonary colonization with Pseudomonas aeruginosa defined according to modified Leeds criteria
  6. fBronchiectasis revealed by chest CT scan. CFTR-RD CFTR-related disease, PS prenatal screening, RS respiratory symptoms, EI electrolyte imbalance, FTT failure to thrive, GS gastrointestinal symptoms, FH family history, ND not defined